GNA15
Basic information
Region (hg38): 19:3136033-3163749
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNA15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 3 |
Variants in GNA15
This is a list of pathogenic ClinVar variants found in the GNA15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-3136461-C-T | not specified | Uncertain significance (Jul 14, 2022) | ||
19-3136473-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
19-3136498-G-C | not specified | Uncertain significance (May 11, 2022) | ||
19-3136518-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
19-3136547-T-G | not specified | Uncertain significance (Oct 07, 2024) | ||
19-3136569-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
19-3148647-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
19-3148650-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
19-3148657-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
19-3148660-A-T | not specified | Uncertain significance (Feb 27, 2024) | ||
19-3148707-G-C | not specified | Uncertain significance (Oct 29, 2024) | ||
19-3148723-T-C | not specified | Uncertain significance (Mar 01, 2023) | ||
19-3150141-G-A | Benign (Dec 04, 2018) | |||
19-3150267-T-A | not specified | Uncertain significance (Mar 07, 2023) | ||
19-3151717-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
19-3151725-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
19-3151726-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
19-3151765-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
19-3151771-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
19-3151782-G-A | Benign (Dec 04, 2018) | |||
19-3151816-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
19-3151825-A-G | not specified | Uncertain significance (Mar 27, 2023) | ||
19-3157732-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
19-3157735-T-G | not specified | Uncertain significance (Jul 31, 2024) | ||
19-3157796-C-T | Benign (Dec 04, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GNA15 | protein_coding | protein_coding | ENST00000262958 | 7 | 27577 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00597 | 0.990 | 125729 | 1 | 17 | 125747 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 200 | 253 | 0.792 | 0.0000176 | 2428 |
Missense in Polyphen | 66 | 92.759 | 0.71152 | 887 | ||
Synonymous | -0.601 | 117 | 109 | 1.07 | 0.00000810 | 714 |
Loss of Function | 2.51 | 7 | 18.8 | 0.373 | 9.84e-7 | 205 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000554 | 0.0000544 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.0000907 | 0.0000791 |
Middle Eastern | 0.0000554 | 0.0000544 |
South Asian | 0.0000704 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems.;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Chagas disease (American trypanosomiasis) - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Platelet Aggregation Inhibitor Pathway, Pharmacodynamics;Endothelin Pathways;Human Complement System;G Protein Signaling Pathways;Signaling by GPCR;Signal Transduction;Thromboxane signalling through TP receptor;Metabolism;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;Regulation of insulin secretion;Signal amplification;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation;ADP signalling through P2Y purinoceptor 1;fmlp induced chemokine gene expression in hmc-1 cells;Hemostasis;Thromboxane A2 receptor signaling;Integration of energy metabolism;G alpha (q) signalling events;GPCR downstream signalling;PAR4-mediated thrombin signaling events;PAR1-mediated thrombin signaling events;LPA receptor mediated events;IL8- and CXCR1-mediated signaling events;S1P3 pathway;Arf6 signaling events;Plasma membrane estrogen receptor signaling;Sphingosine 1-phosphate (S1P) pathway;Endothelins;IL8- and CXCR2-mediated signaling events;S1P2 pathway
(Consensus)
Intolerance Scores
- loftool
- 0.105
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.51
Haploinsufficiency Scores
- pHI
- 0.0681
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.766
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gna15
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;activation of phospholipase C activity;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;platelet activation;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;phospholipase C-activating dopamine receptor signaling pathway
- Cellular component
- heterotrimeric G-protein complex;plasma membrane
- Molecular function
- G protein-coupled receptor binding;GTPase activity;GTP binding;G-protein beta/gamma-subunit complex binding;metal ion binding